Patient Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: Findings from a Patient Survey in Europe

INTRODUCTION: Benepali(®) was the first etanercept (Enbrel(®)) biosimilar to be approved in the European Union. Both Benepali and Enbrel are available as autoinjector devices. In a recent survey, nurses from France, Germany, Italy, Spain, and the United Kingdom (UK) reported that their patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakur, Kunal, Biberger, Anna, Handrich, Alexandra, Rezk, Mourad Farouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127972/
https://www.ncbi.nlm.nih.gov/pubmed/27817152
http://dx.doi.org/10.1007/s40744-016-0048-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127972/
https://www.ncbi.nlm.nih.gov/pubmed/27817152
http://dx.doi.org/10.1007/s40744-016-0048-9

Ejemplares similares